These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment of invasive candidal infections: systematic review and meta-analysis. Gafter-Gvili A, Vidal L, Goldberg E, Leibovici L, Paul M. Mayo Clin Proc; 2008 Sep; 83(9):1011-21. PubMed ID: 18775201 [Abstract] [Full Text] [Related]
28. Combination antifungal therapy: where are we now, and where are we going? Marr K. Oncology (Williston Park); 2004 Nov 16; 18(13 Suppl 7):24-9. PubMed ID: 15651179 [Abstract] [Full Text] [Related]
29. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy. Magill SS, Shields C, Sears CL, Choti M, Merz WG. J Clin Microbiol; 2006 Feb 16; 44(2):529-35. PubMed ID: 16455909 [Abstract] [Full Text] [Related]
32. Voriconazole: review of a broad spectrum triazole antifungal agent. Kofla G, Ruhnke M. Expert Opin Pharmacother; 2005 Jun 16; 6(7):1215-29. PubMed ID: 15957974 [Abstract] [Full Text] [Related]
33. Caspofungin versus amphotericin B for invasive candidiasis. Brown AL, Greig JR. N Engl J Med; 2003 Mar 27; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396 [No Abstract] [Full Text] [Related]
34. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species]. Altuncu E, Bilgen H, Cerikçioğlu N, Ilki A, Ulger N, Bakır M, Akman I, Ozek E. Mikrobiyol Bul; 2010 Oct 27; 44(4):593-603. PubMed ID: 21063972 [Abstract] [Full Text] [Related]